Hjem › Kolesterol › Alabama
Kliniske studier for Kolesterol i Alabama
5 studier for Kolesterol søker deltakere på steder i Alabama.
Offisiell studietekst (engelsk)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Advanced Cardiovascular LLC, Alexander City
- Cardiology, PC, Birmingham
- Heart Center Research, LLC, Huntsville
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Dothan
RekruttererFase 3
Alder 18 til 130 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- G and L Research LLC, Foley
- The Center for Clinical Trials, Saraland
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 30. jul. 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Pinnacle Research Group, Anniston
- Cullman Clinical Trials, Cullman
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07477704FELLAShip to Better Health
- The Worship Center Cristian Church, Birmingham
Rekrutterer
Alder 18 og eldre · Menn · Oppdatert 22. jan. 2026 · NCT07220213Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.